Is a complete MBX research report available?

No complete published report is available for MBX Biosciences, Inc. (MBX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

MBX Biosciences, Inc. (MBX)

NASDAQ: MBX · USD

$64.0

+3.90 (+6.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MBX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3B
Net income (ttm)	-86.6M
EPS (ttm)	-$2.18
Shares out	47.6M
Volume	564,612
Price target	$80.4	+25.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -86.6M
EPS (ttm): -$2.18
Market cap: 3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MBX indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001776111
Company name	MBX Biosciences, Inc.
Country	United States
Country code	US
Cusip	55287L101
Employees	63
Employees Change	20%
Employees Change Percent	46.51
Enterprise value	$2.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-09-13
Isin	US55287L1017
Last refreshed	2026-07-30
Market cap	$3B
Market cap category	Mid-Cap
Price	$63.96
Price currency	USD
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	2834
Symbol	MBX
Tags	weight-loss
Website	https://mbxbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.84%
FCF yield	-2.62%
P/B ratio	6.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-86.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-17.68
ROCE	-22.55
ROE	-25.73
ROIC	-18.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	340.03%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$452.7M
Cash	$440M
Current Assets	$448.5M
Current Liabilities	$14.6M
Debt	$555,000
Debt Equity	$0
Equity	$437.8M
Liabilities	$14.9M
Long Term Assets	$4.2M
Long Term Liabilities	$378,000
Net Cash	$439.4M
Net Cash By Market Cap	$14.43
Net Cash Growth	82.59%
Net Debt Equity	$-1
Tangible Book Value	$437.8M
Tangible Book Value Per Share	$9.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	30.79
Net Working Capital	$-5.8M
Quick ratio	30.42
Working Capital	$434M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-112.87%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	339.59%
200-day SMA	34.44
50-day SMA	46.46
50-day SMA vs 200-day SMA	50over200
All Time High	66.66
All Time High Change	-4.05%
All Time High Date	2026-07-24
All Time Low	4.81
All Time Low Change	1,230.56%
All Time Low Date	2025-04-07
ATR	4.48
Beta1y	1.44
Beta2y	2
Ch YTD	102.8
High	65.99
High52	66.66
High52 Date	2026-07-24
High52ch	-4.05%
Low	60.58
Low52	9.63
Low52 Date	2025-09-12
Low52ch	564.17%
Ma50ch	37.68%
Premarket Change Percent	0.27
Premarket Price	$60.22
Premarket Volume	3,782
Price vs 200-day SMA	85.72%
RSI	62.85
RSI Monthly	77.22
RSI Weekly	75.05
Sharpe ratio	1.6x
Sortino ratio	3.95
Total Return	-112.87%
Tr YTD	102.8
Tr1m	22.27%
Tr1w	9.71%
Tr3m	120.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	6
Analyst Price Target Top	$80.25
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.62
Operating Income	$-98.8M
Price target	$80.4
Price Target Change	$25.7
Price Target Change Top	$25.47

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,055,004%
Float Percent	56.84%
Shares Insiders	2.92%
Shares Institutions	84.48%
Shares Out	47,597,536
Shares Qo Q	3.81%
Shares Yo Y	112.87%
Short Float	21.35%
Short Ratio	5.52
Short Shares	12.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-92.1M
Adjusted OCF	-89,801,000
Average Volume	780,030.85x
Bv Per Share	9.2
CAPEX	$-2.3M
Ch1m	22.27
Ch1w	9.71
Ch1y	339.6
Ch3m	120.2
Ch6m	78.51
Change	6.49%
Change From Open	3.53
Close	60.06
Days Gap	2.86
Depreciation Amortization	235,000
Dollar Volume	36,112,583.5
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-98.8M
EBITDA	$-98.6M
EPS	$-2.18
F Score	2
FCF	$-79.8M
FCF EV Yield	-3.06x
FCF Per Share	$-1.68
Financing CF	277,023,000
Fiscal Year End	December
Founded	2,018
Investing CF	-184,028,000
Ipr	299.8
Iprfo	178.1
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	37.82
Ma150ch	69.1%
Ma20	60.5
Ma20ch	5.71%
Net CF	15,516,000
Next Earnings Date	2026-08-10
Open	61.78
Optionable	Yes
Position In Range	62.48
Post Close	63.96
Postmarket Change Percent	0.06
Postmarket Price	$64
Ppne	3,586,000
Pre Close	60.06
Price Date	2026-07-29
Ptbv Ratio	6.95
Relative Volume	0.72x
Share Based Comp	12,322,000
Tr6m	78.51%
Us State	Indiana
Volume	564,612

MBX Biosciences, Inc. (MBX)

Coverage state: Market snapshot only — no published research

Generate the first MBX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · MBX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MBX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MBX

Frequently asked questions